Efter behandling med 1 mg/ kg hver anden uge i 24 uger kunne 0, 3 mg/ kg hver anden uge i 18 måneder opretholde clearance for cellulær GL- 3 i nyrernes kapillære endothelium, andre typer nyreceller og huden (hudens kapillære endothelium) hos de fleste patienter.
Following treatment with 1 mg/ kg every other week for 24 weeks, a dose regimen of 0.3 mg/ kg every 2 weeks for 18 months was able to maintain the clearance of cellular GL-3 in the capillary endothelium of the kidney, other kidney cell types and skin (superficial skin capillary endothelium) in the majority of patients.